References
- Levin M, Schmader K, Oxman M. Varicella and Herpes Zooster. In: Kang S, Amagai M, Bruckner AL, et al., editors. Fitzpatrick’s Dermatology in General Medicine. 9th ed. New York: McGraw Hill; 2019:3035–3058.
- Ellis DL, Barsell A, Riahi RR, Stumpf B. Varicella zoster virus encephalitis in a patient with disseminated herpes zoster: report and review of the literature. Dermatol Online J. 2015;21(3). doi:10.5070/D3213022994
- Bollea-Garlatti ML, Bollea-Garlatti LA, Vacas AS, et al. Clinical characteristics and outcomes in a population with disseminated herpes zoster: a retrospective cohort study. Actas Dermosifiliogr. 2017;108(2):145–152. doi:10.1016/j.ad.2016.10.00927938930
- Belendiuk K, Ding Y, Chawla D, Cascino M. Herpes zooster and disseminated zooster in systemic lupus erythematosus and lupus nephritis: incidence rates in real-world claims data. In: Arthritis & Rheumatology. Vol. 70. USA: Wiley; 2018.
- Oladokun RE, Olomukoro CN, Owa AB. Disseminated herpes zoster ophthalmicus in an immunocompetent 8-year old boy. Clin Pract. 2013;3(2):40–42. doi:10.4081/cp.2013.e16
- Laing KJ, Ouwendijk WJ, Koelle DM, Verjans GM. Immunobiology of varicella-zoster virus infection. J Infect Dis. 2018;218(suppl_2):S68–S74. doi:10.1093/infdis/jiy40330247598
- Pusponegoro E, Nilasari H, Lumintang H, Niode N, Daili S, Djausi S. Buku Panduan Herpes Zoster Indonesia 2014. Jakarta: Fakultas kedokteran Universitas Indonesia; 2014.
- Gershon AA, Breuer J, Cohen JI, et al. Varicella zoster virus infection. Nat Rev Dis Primers. 2015;1:15016. doi:10.1038/nrdp.2015.1627188665
- Singh M, Breuer J. Varicella zooster virus infections. In: Harper J, Oranje AP, Bodemer C, et al., editors. Harper’s Textbook of Pediatric Dermatology. John Wiley & Sons; 2019:612–623.
- Cohen JI. Herpes zoster. N Engl J Med. 2013;369(3):255–263. doi:10.1056/NEJMcp130267423863052
- Marra F, Parhar K, Huang B, Vadlamudi N. Risk factors for herpes zoster infection: a meta-analysis. Open Forum Infect Dis. 2020;7. doi:10.1093/ofid/ofaa005
- Takayama N, Yamada H, Kaku H. Herpes zoster in immunocompetent and immunocompromised Japanese children. Pediatr Int. 2000;42(3):275–279. doi:10.1046/j.1442-200x.2000.01227.x10881585
- Chen D, Li H, Xie J, Zhan Z, Liang L, Yang X. Herpes zoster in patients with systemic lupus erythematosus: clinical features, complications and risk factors. Exp Ther Med. 2017;14(6):6222–6228. doi:10.3892/etm.2017.529729285180
- Nagasawa K, Yamauchi Y, Tada Y, Kusaba T, Niho Y, Yoshikawa H. High incidence of herpes zoster in patients with systemic lupus erythematosus: an immunological analysis. Ann Rheum Dis. 1990;49:630‑633. doi:10.1136/ard.49.8.630
- Ng WL, Chu CM, Wu AK, Cheng VC, Yuen KY. Lymphopenia at presentation is associated with increased risk of infections in patients with systemic lupus erythematosus. QJM. 2006;99:37‑47. doi:10.1093/qjmed/hci155
- Hu SC, Lin CL, Lu YW, et al. Lymphopaenia, anti‑Ro/anti‑RNP autoantibodies, renal involvement and cyclophosphamide use correlate with increased risk of herpes zoster in patients with systemic lupus erythematosus. Acta Derm Venereol. 2013;93:314‑318. doi:10.2340/00015555-1454
- Levin MJ, Smith JG, Kaufhold RM, et al. Decline in varicella‑zoster virus (VZV)‑specific cell‑mediated immunity with increasing age and boosting with a high‑dose VZV vaccine. J Infect Dis. 2003;188:1336‑1344. doi:10.1086/379048
- Sayeeda A, Al Arfaj H, Khalil N, Al Arfaj AS. Herpes zoster infections in SLE in a university hospital in Saudi Arabia: risk factors and outcomes. Autoimmune Dis. 2010;2010:1–5. doi:10.4061/2010/174891
- Chakranorty U, Chandra A, Sil A, Biswas SK. Elderly immunocompetent man presenting with disseminated cutaneous herpes zoster. BMJ Case Rep. 2020;13(8):e237480. doi:10.1136/bcr-2020-237480